Diagnosis of Depression: Psychometric Examination of the Russian Version of the Patient Health Questionnaire (PHQ-9)

The aim of this study was to examine the psychometric properties of the Russian version of the Patient Health Questionnaire-9 (PHQ-9). The participants were 1800 Russians, including 1076 (59.8%) women and 724 (40.2%) men aged 18 to 90 years (M=30.2; SD=14.5). They completed the Russian version of the PHQ-9. The results showed that the Russian PHQ-9 had high internal reliability (α-Cronbach=0.89). The single-factor structure of the Russian PHQ-9, confirmed by exploratory factor analysis and confirmatory factor analysis, highlights the factor validity of the adapted questionnaire. Among the Russians surveyed, 34.4% had high depression, from 22.1% to 81.7% of the participants reported various symptoms of depressive disorders. Depressive symptoms were more common in women and younger respondents, with the exception of complaints about sleep problems, which were more common in older respondents. Further psychometric tests of the Russian PHQ-9 should attract objective data and people with diagnosed depressive disorders.

1. Nestik T.A. Perezhivanie epidemiologicheskoi ugrozy rossiyanami kak sotsial'no-psikhologicheskii fenomen: rezul'taty serii empiricheskikh issledovanii [The experience of an epidemiological threat by Russians as a socio-psychological phenomenon: The results of a series of empirical studies]. Vliyanie pandemii na lichnost' i obshchestvo: psikhologicheskie mekhanizmy i posledstviya / Otv. red. T.A. Nestik, A.L. Zhuravlev, A.E. Vorob'eva. Moscow: Izd-vo «Institut psikhologii RAN»=The impact of the pandemic on the individual and society: psychological mechanisms and consequences / Ed. T.A. Nestik, A.L. Zhuravlev, A.E. Vorobyova. Moscow: Publishing House «Institute of Psychology of the Russian Academy of Sciences», 2021, pp. 19–125. DOI: 10.38098/fund_21_0442_02 (in Russ.).
2. Pogosova N.V., Dovzhenko T.V., Babin A.G. et al. Russkoyazychnaya versiya oprosnikov PHQ-2 i 9: chuvstvitel'nost' i spetsifichnost' pri vyyavlenii depressii u patsientov obshchemeditsinskoi ambulatornoi praktiki [Russian version of PHQ-2 and 9 questionnaires: Sensitivity and specifity in detection of depression in outpatient general medical practice]. Kardiovaskulyarnaya terapiya i profilaktika=Cardiovascular Therapy and Prevention, 2014, vol. 13, no. 3, pp. 18–24. DOI: 10.15829/1728-8800-2014-3-18-24 (in Russ., abstr. in Engl.).
3. Khramov E.V., Ivanov V.S. Sovremennye zarubezhnye issledovaniya depressivnykh rasstroistv v period pandemii COVID-19 [Modern foreign studies of depressive disorders during the COVID-19 pandemic]. Sovremennaya zarubezhnaya psikhologiya=Journal of Modern Foreign Psychology, 2021, vol. 10, no. 1, pp. 39–47. DOI: 10.17759/jmfp.2021100104 (in Russ., abstr. in Engl.).
4. Shalnova S.A., Evstifeeva S.E., Deev A.D. et al. Rasprostranennost' trevogi i depressii v razlichnykh regionakh Rossiiskoi Federatsii i ee assotsiatsii s sotsial'no-demograficheskimi faktorami (po dannym issledovaniya ESSE-RF) [The prevalence of anxiety and depression in different regions of the Russian Federation and its association with sociodemographic factors (according to the data of the ESSE-RF study)]. Terapevticheskii arkhiv=Therapeutic Archive, 2014, vol. 86, no. 12, pp. 53–60. DOI: 10.17116/terarkh2014861253-60 (in Russ., abstr. in Engl.).
5. Aslan J., Cova F., Saldivia S. et al. Psychometric properties of the Patient Health Questionnaire-9 in elderly Chilean primary care users. Frontiers in Psychiatry, 2020, vol. 11, ID 555011. DOI: 10.3389/fpsyt.2020.555011
6. Beach S.R., Januzzi J., Mastromauro C.A. et al. Patient Health Questionnaire-9 score and adverse cardiac outcomes in patients hospitalized for acute cardiac disease. Journal of Psychosomatic Research, 2013, vol. 75, no. 5, pp. 409–413. DOI: 10.1016/j.jpsychores.2013.08.001
7. Bombardier C.H., Kalpakjian C.Z., Graves D.E. et al. Validity of the Patient Health Questionnaire-9 in assessing major depressive disorder during inpatient spinal cord injury rehabilitation. Archives of Physical Medicine and Rehabilitation, 2012, vol. 93, no. 10, pp. 1838–1845. DOI: 10.1016/j.apmr.2012.04.019
8. Carballeira Y., Dumont P., Borgacci S. et al. Criterion validity of the French version of Patient Health Questionnaire (PHQ) in a hospital department of internal medicine. Psychology and Psychotherapy, 2007, vol. 80, pp. 69–77. DOI: 10.1348/147608306X103641
9. Caroll H.A., Hook K., Perez O.F.R. et al. Establishing reliability and validity for mental health screening instruments in resource-constrained settings: Systematic review of the PHQ-9 and key recommendations. Psychiatry Research, 2020, vol. 291, ID 113236. DOI: 10.1016/j.psychres.2020.113236
10. Cholera R., Gaynes B.N., Pence B.W. et al. Validity of the Patient Health Questionnaire-9 to screen for depression in a high-HIV burden primary healthcare clinic in Johannesburg, South Africa. Journal of Affective Disorders, 2014, vol. 167, pp. 160–166. DOI: 10.1016/j.jad.2014.06.003
11. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet, 2021, vol. 398, pp. 1700-1712. DOI: 10.1016/S0140-6736(21)02143-7
12. Gilman S.E., Sucha E., Kingsbury M. et al. Depression and mortality in a longitudinal study: 1952–2011. Canadian Medical Association Journal, 2017, vol. 189, no. 42, pp. 1304–1310. DOI: 10.1503/cmaj.170125
13. Grapp M., Terhoeven V., Nikendei C., et al. Screening for depression in cancer patients using the PHQ-9: The accuracy of somatic compared to non-somatic items. Journal of Affective Disorders, 2019, vol. 254, pp. 74–81. DOI: 10.1016/j.jad.2019.05.026
14. Kessler R.C., Bromet E.J. The epidemiology of depression across cultures. Annual Review of Public Health, 2013, vol. 34, pp. 119–138. DOI: 10.1146/annurev-publhealth-031912-114409
15. Kim Y.E., Lee B. The psychometric properties of the Patient Health Questionnaire-9 in a sample of Korean university students. Psychiatry Investigation, 2019, vol. 16, no. 12, pp. 904–910. DOI: 10.30773/pi.2019.0226
16. Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ-9. Validity of a brief depression severity measure. Journal of General Internal Medicine, 2001, vol. 16, no. 9, pp. 606–613. DOI: 10.1046/j.1525-1497.2001.016009606.x
17. Lim G.Y., Tam W.W., Lu Y., Ho C.S., Zhang M.W., Ho R.C. Prevalence of depression in the community from 30 countries between 1994 and 2014. Scientific Reports, 2018, vol. 8, p. 2861. DOI: 10.1038/s41598-018-21243-x
18. Liu S.I., Yeh Z.T., Huang H.C. et al. Validation of Patient Health Questionnaire for depression screening among primary care patients in Taiwan. Comprehensive Psychiatry, 2011, vol. 52, no. 1, pp. 96-101. DOI: 10.1016/j.comppsych.2010.04.013
19. López-Guerra V.M., López-Núñez C., Vaca-Gallegos S.L. et al. Psychometric properties and factor structure of the Patient Health Questionnaire-9 as a screening tool for depression among Ecuadorian college students. Frontiers in Psychology, 2022, vol. 13, ID 813894. DOI: 10.3389/fpsyg.2022.813894
20. Maroufizadeh S., Omani-Samani R., Almasi-Hashiani A., Amini P., Sepidarkish M. The reliability and validity of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with infertility. Reproductive Health, 2019, vol. 16, p. 137. DOI: 10.1186/s12978-019-0802-x
21. Mazza M.G., Palladini M., Poletti S. et al. Post-COVID-19 depressive symptoms: Epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs, 2022, vol. 36, pp. 681-702. DOI: 10.1007/s40263-022-00931-3
22. Muramatsu K., Miyaoka H., Kamijima K. et al. Performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care. General Hospital Psychiatry, 2018, vol. 52, pp. 64-69. DOI: 10.1016/j.genhosppsych.2018.03.007
23. Policastro F., Rossi A., Sulaiman H.M. et al. Adaptation, validity, and reliability of the Patient Health Questionnaire (PHQ-9) in the Kurdistan region of Iraq. Healthcare (Basel), 2023, vol. 11, no. 3, p. 598. DOI: 10.3390/healthcare11040598
24. Rahman M.A., Dhira T.A., Sarker A.R., Mehareen J. Validity and reliability of the Patient Health Questionnaire scale (PHQ-9) among university students of Bangladesh. PLoS One, 2022, vol. 17, no. 6, e0269634. DOI: 10.1371/journal.pone.0269634
25. Rosario-Hernández E., Rovira-Millán L.V., Merino-Soto C. et al. Review of the psychometric properties of the Patient Health Questionnaire-9 (PHQ-9) Spanish version in a sample of Puerto Rican workers. Frontiers in Psychiatry, 2023, vol. 14, ID 1024676. DOI: 10.3389/fpsyt.2023.1024676
26. Shevlin M., Butter S., McBride O. et al. Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic. BMC Psychiatry, 2022, vol. 22, ID 154. DOI: 10.1186/s12888-022-03787-5
27. Snijkers J.T., van den Oever W., Weerts Z.Z.R.M. et al. Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome. Neurogastroenterology and Motility, 2021, vol. 33, no. 12, e14161. DOI: 10.1111/nmo.14161
28. Tavakol M., Dennick R. Making sense of Cronbach’s alpha. International Journal of Medical Education, 2011, vol. 2, pp. 53–55. DOI: 10.5116/ijme.4dfb.8dfd
29. Tele A.K., Carvajal-Velez L., Nyongesa V. et al. Validation of the English and Swahili adaptation of the Patients Health Questionnaire-9 for use among adolescents in Kenya. Journal of Adolescent Health, 2023, vol. 72, no. 1, pp. 61-70. DOI: 10.1016/j.jadohealth.2022.10.003
30. Voshaar R.C.O., Dimitriadis M., vandenBrink R.H.S. et al. A 6-year prospective clinical cohort study on the bidirectional association between frailty and depressive disorder. International Journal of Geriatric Psychiatry, 2021, vol. 36, no. 11, pp. 1699-1707. DOI: 10.1002/gps.5588
31. Wang W., Bian Q., Zhao Y. et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population. General Hospital Psychiatry, 2014, vol. 36, no. 5, pp. 539-544. DOI: 10.1016/j.genhosppsych.2014.05.021
32. Weisman A., Yona T., Gottlieb U. et al. The reliability and validity of an online version of the Hebrew Patient Health Questionnaire (PHQ-9) in the general population. Israel Journal of Psychiatry, 2022, vol. 59, no. 2, pp. 28-32. DOI: 10.1101/2021.07.13.21260485
33. Wisting L., Johnson S.U., Bulik C.M. et al. Psychometric properties of the Norwegian version of the Patient Health Questionnaire-9 (PHQ-9) in a large female sample of adults with and without eating disorders. BMC Psychiatry, 2021, vol. 21, p. 6. DOI: 10.1186/s12888-020-03013-0
34. Ye X., Shu H.L., Fent X. Reliability and validity of the Chinese version of the Patient Health Questionnaire-9 (C-PHQ-9) in patients with psoriasis: A cross-sectional study. BMJ Open, 2020, vol. 10, no. 7, e033211. DOI: 10.1136/bmjopen-2019-03321